Today: 7 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

Merck shares fell 1.1% to $109.27 Monday amid speculation over a possible $28–32 billion acquisition of Revolution Medicines, though no deal has been finalized. The SPDR S&P Biotech ETF dropped 2.1%. Analysts estimate Revolution’s RAS inhibitor drugs could generate over $10 billion in sales by 2035. Merck also faces a potential $2 billion annual revenue hit after U.S. vaccine schedule changes affecting Gardasil and RotaTeq.
12 January 2026
··
Goldman Sachs stock ticks up as Powell probe threat, rate-cap talk keep banks on edge

Goldman Sachs stock ticks up as Powell probe threat, rate-cap talk keep banks on edge

Goldman Sachs shares rose 0.6% to $944.73 in Monday afternoon trading ahead of fourth-quarter earnings due Jan. 15. Markets weighed Trump’s proposed 10% cap on credit-card interest rates and threats to indict Fed Chair Jerome Powell. Traders are focused on Tuesday’s U.S. CPI report and major bank earnings. Goldman’s chief economist now expects Fed rate cuts in June and September.
12 January 2026
···
Mastercard stock drops as Trump’s 10% credit-card rate cap plan rattles card-linked names

Mastercard stock drops as Trump’s 10% credit-card rate cap plan rattles card-linked names

Mastercard shares fell 1.7% to $565.93 Monday after President Trump called for a one-year 10% cap on credit card interest rates, sending card stocks lower. Visa dropped 1.7% and American Express slid 4.2%. Analysts said such a cap would need Congressional approval and warned it could hurt lender profits. Separately, Google named Mastercard as an endorser of its new Universal Commerce Protocol for AI-driven shopping.
12 January 2026
·
Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Johnson & Johnson shares rose 2.3% to $209.03 after new data showed its drug Rybrevant, combined with chemotherapy, produced a 51% response rate in metastatic colorectal cancer. The results, from the OrigAMI-1 trial, included a 73% response rate in first-line patients. The company’s fourth-quarter earnings report is due Jan. 21. J&J recently struck a deal with the Trump administration to lower U.S. drug prices.
12 January 2026
···
Reddit stock (RDDT) slips as insider selling hits the tape; CPI report is the next test

Reddit stock (RDDT) slips as insider selling hits the tape; CPI report is the next test

Reddit shares fell 1.1% to $241.85 Monday as the S&P 500 and Nasdaq-100 ETFs edged up 0.2%. Wells Fargo raised its price target to $207 but kept an equal-weight rating. SEC filings showed Reddit’s chief legal officer and CFO sold shares under preset trading plans. Daily active users rose 19% to 116 million, with revenue up 68% to $585 million.
12 January 2026
········
Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble shares rose about 1% to $143.29 Monday afternoon, outpacing the S&P 500’s 0.2% gain as consumer-staples stocks advanced. The move came amid renewed market volatility after news broke of a criminal probe into Fed Chair Jerome Powell. Investors are watching U.S. inflation data and P&G’s Jan. 22 earnings report for further direction.
12 January 2026
··
Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

Thermo Fisher shares fell 1.8% Monday after a regulatory filing showed COO Michel Lagarde and EVP Frederick M. Lowery will depart in the first quarter. The company announced new AI-focused partnerships with TetraScience and Nvidia. Investors await Tuesday’s J.P. Morgan Healthcare Conference and the Jan. 29 earnings report for further signals on demand.
12 January 2026
··
Lockheed Martin stock today: LMT edges up as defense names catch a safety bid

Lockheed Martin stock today: LMT edges up as defense names catch a safety bid

Lockheed Martin shares rose $2.70 to $545.62 Monday as investors moved into defense stocks ahead of Tuesday’s CPI report and amid market volatility. Gains followed threats from the Trump administration to indict Fed Chair Jerome Powell and a proposal to cap credit card interest rates, which pressured financial stocks. Gold and defense shares rallied after Trump floated seizing Greenland. Lockheed reports Q4 earnings Jan. 29.
12 January 2026
···
AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie shares fell 0.6% to $218.81 after announcing a $650 million licensing deal with China’s RemeGen for the experimental cancer drug RC148. RemeGen could receive up to $4.95 billion in milestones and royalties. AbbVie also agreed to buy a device manufacturing plant in Tempe, Arizona, from West Pharmaceutical Services. The S&P health-care sector declined while the broader market rose.
12 January 2026
···
ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

Goldman Sachs initiated coverage of ServiceNow with a Buy rating and a $205 price target Monday, sending shares up 0.2% to around $142 in afternoon trading. The move follows a 3% drop last week. Investors are focused on ServiceNow’s Jan. 28 earnings report for signals on 2026 growth and demand. Stifel recently cut its price target to $200, citing concerns over federal contract trends.
12 January 2026
···
1 … 230 231 232 233 234 … 606

Stock Market Today

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026
Walmart shares climbed 3.34% to $131.18 Friday, pushing its market value to about $1.05 trillion as the Dow closed above 50,000 for the first time. Retail stocks mostly gained, with Target up 4.24% and Costco up 1.20%, while Amazon dropped 5.55%. Investors await Walmart’s fiscal Q4 results on Feb. 19 and key U.S. economic data next week.
Go toTop